Skip to content
Review Open access

The human microbiome and its role in health and disease

Sep 2026 · Microbiologia Medica · 0 citations · 107 references

TL;DR

This narrative review synthesizes current evidence on microbiome composition, function, and clinical significance across health and disease, and addresses early-life microbiome establishment, site-specific microbial communities, and mechanisms linking microbial imbalance to disease pathogenesis, including the gut-brain, gut-skin, and gut-kidney axes.

Abstract

The human microbiome encompasses trillions of microorganisms, including bacteria, archaea, fungi, viruses, and protozoa, colonizing virtually every body surface. These communities contribute to digestion, immune regulation, metabolic homeostasis, and protection against pathogens. Disruption of microbial balance, termed dysbiosis, is associated with conditions spanning gastrointestinal, metabolic, neurological, psychiatric, immune-mediated, cardiovascular, and renal diseases. This narrative review synthesizes current evidence on microbiome composition, function, and clinical significance across health and disease. We address early-life microbiome establishment, site-specific microbial communities, and mechanisms linking microbial imbalance to disease pathogenesis, including the gut-brain, gut-skin, and gut-kidney axes. We distinguish microbial associations from causal relationships, acknowledge research limitations, and outline emerging therapeutic strategies, including probiotics, prebiotics, Fecal Microbiota Transplantation (FMT), and precision microbiome-based medicine. Future research should prioritize longitudinal multi-omics studies, diverse population sampling, and standardized methodologies.

Read PDF

Similar papers

Review Open access Sep 2026

The Oral Microbiome and Systemic Disease: From Microbial Dysbiosis to Therapeutic Opportunities

The oral microbiome is a complex community of microorganisms that maintain oral homeostasis and continuously engage host immune and metabolic pathways. The disruption of this ecosystem can lead to dysbiosis, a condition that is increasingly linked to systemic diseases relating to the cardiovascular, metabolic, respirat...

Ejaz Ahmed, Ayisha Yousaf, M. Qasim et al. · 0 citations
Review Open access Oct 2026

Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging

The human gut harbors a diverse and dense microbial community that maintains metabolic, immune, and intestinal homeostasis through a symbiotic relationship with the host. Aging is a complex biological process that involves alterations in the gut microbiome, including decreased microbial diversity and a decline in b...

M. Islam, Gabsik Yang, Ki-Sung Kang · 0 citations
Review Open access Nov 2026

Targeting the Skin Microbiome in Dermatology: Translational Hype or Emerging Therapeutic Modality?

The human skin microbiome is a complex network of microorganisms, including bacteria, fungi, viruses, and archaea, that exist in a mutualistic relationship with the host. These microorganisms play important roles in maintaining skin homeostasis, defense against pathogens, regulation of immune response, and antimicrobia...

R. A. Syed, Ayesha Ahmed, Uzma Hayat et al. · 0 citations
Review Open access Oct 2026

Gut Microbiota in Psoriasis: Evidence for Dysbiosis, Pathological Mechanisms, Causality, and Therapeutic Implications

Abstract Psoriasis is a chronic inflammatory skin disease driven by genetic susceptibility, environmental triggers, and immune dysregulation, with a global prevalence of approximately 2%–3%. In recent years, the gut microbiota has garnered increasing attention as a key interface linking environmental factors to host im...

Na-Na Zhao, Wen-Bing Cao, Wei-Jia Liu et al. · 0 citations
Review Sep 2026

Microbiome-Driven Strategies in the Management of Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) is a chronic, relapsing inflammatory disorder of the gastrointestinal tract that arises from complex interactions among genetic susceptibility, environmental factors, immune dysregulation, and alterations in the gut microbiota. Increasing evidence has established gut microbial dysbi...

Hassham Anwar, Shashank Soni · 0 citations
Review Open access Oct 2026

Fecal microbiota transplant in the treatment of inflammatory bowel diseases: new perspectives on delivery, mechanism, and clinical positioning.

The evolving role of FMT within the therapeutic framework of chronic inflammation, focusing specifically on IBD, is examined and the variable clinical outcomes in IBD are compared with the highly successful model of recurrent CDI, highlighting mechanistic and clinical determinants of response in a different disease con...

Anum Javed, Despoina Chrysostomou, J. Marchesi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.